Study to Test Pneumococcal Vaccine in Older Adult
ScienceDaily (Oct. 15, 2012) — Researchers plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier generation vaccine against pneumonia and other pneumococcal diseases.
The study supported by the National Institutes of Health will compare two dosages of a pneumococcal vaccine approved for children ages 6 weeks to 5 years, and adults 50 and older. The trial will enroll up to 882 men and women ages 55 to 74
Mi vida loca: full-time WOHM, frugalista, foodie wannabe, 10+ years of TCOYF
R-E-S-P-E-C-T spells BRAND NEW User Agreement!!
|11 members and 11,190 guests|
|jamesmorrow , katelove , manyhatsmom , Michele123 , RollerCoasterMama , scaramouche131 , zebra15|
|Most users ever online was 449,755, 06-25-2014 at 12:21 PM.|